Skip to content
The Nexus
DossierENTITY

Xofluza

Coverage of Xofluza in the Nexus archive.

Earliest in view: Jun 18 · 21:41 UTCMost recent: Jun 19 · 13:00 UTC
Co-mentioned in this coverage
FDAorganization2baloxavir marboxiltopic1Influenzatopic1baloxavir marboxilproduct1flutopic1antiviral medicationstopic1flu shottopic1generic medicationtopic1Dr. Nandiperson1
Recent coverage
  • HEALTHJun 19 · 13:00 UTCMEDPAGE TODAY
    Generic Single-Dose Flu Antiviral Gets FDA's Blessing

    The FDA approved the first generic version of baloxavir marboxil (Xofluza) as a single-dose option to treat or prevent influenza in adults and children 5 years and older. The medication is approved for both treatment and prevention settings.

  • HEALTHJun 18 · 21:41 UTCWXYZ ABC DETROIT
    Ask Dr. Nandi: FDA approves 1st single-dose generic flu treatment ahead of flu season

    The FDA approved the first generic version of Xofluza, a single-dose antiviral flu treatment for people aged 5 and older with symptoms for no more than 48 hours. The generic drug, containing baloxavir marboxil, offers convenience and affordability but is not a substitute for the flu vaccine.

Xofluza · Dossier · The Nexus